Products for Research Use Only
RegisterLogin

Genz-123346

CAT: 0804-HY-12744A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-12744A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Genz-123346 is a potent, orally available glucosylceramide synthase inhibitor. Genz-123346 blocks the conversion of ceramide to glucosylceramide (GL1) and inhibits GM1 with an IC50 value of 14 nM[1].
CAS Number
943344-58-9
UNSPSC
12352005
Target
Glucosylceramide Synthase (GCS)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/Genz-123346.html
Purity
98.86
Solubility
10 mM in DMSO
Smiles
CCCCCCCCC(N[C@H](CN1CCCC1)[C@@H](C2=CC=C(OCCO3)C3=C2)O)=O.O=C(O)[C@H](O)[C@@H](O)C(O)=O.[1/2]
Molecular Formula
C24H38N2O4·1/2C4H6O6
Molecular Weight
493.63
References & Citations
[1]Zhao H, et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes. 2007 May;56 (5) :1210-8.|[2]Chai L, et al. The chemosensitizing activity of inhibitors of glucosylceramide synthase is mediated primarily through modulation of P-gp function. Int J Oncol. 2011 Mar;38 (3) :701-11.|[3]Shen W, et al. Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons. J Neurochem. 2014 Jun;129 (5) :884-94|[4]Natoli TA, et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat Med. 2010 Jul;16 (7) :788-92.|[5]Morace I, et al. Renal globotriaosylceramide facilitates tubular albumin absorption and its inhibitionprotects against acute kidney injury. Kidney Int. 2019 Aug;96 (2) :327-341.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Citation 01
Am J Respir Crit Care Med. 2019 Nov 1;200 (9) :1113-1125. |Faculty of Life Sciences, University College London. 2019 Oct.|Front Pharmacol. 2024 Oct 1:15:1409625.|Hepatol Commun. 2025 Sep 5;9 (9) :e0793.|Int Immunopharmacol. 2025 Sep 13:165:115532.|Nat Cell Biol. 2025 Mar;27 (3) :449-463.|PeerJ. 2021 Sep 14:9:e12138.

Related Products

CatalogName
HY-101526-01GENZ-882706
HY-16228-01Genz-644282
HY-120462Genz-669178
HY-101526RGENZ-882706 (Raceme)
HY-10259PD 123319
HY-117528WAY-123398
HY-P0177-01123C4
HY-1257061233B
HY-10259A-01PD 123319 (ditrifluoroacetate)
HY-176920BRI-12349

Alternative Products

CatalogName
B2286-50genz-123346
MBS130492-01Genz 123346
A21536-10Genz-123346 10mg
A21536-25Genz-123346 25mg
A21536-5Genz-123346 5mg
A21536-1Genz-123346 1mg
MBS384758-01Genz-123346 free base

Popular Products